Latest News for: kelun kelun

Edit

EGFR Non Small Cell Lung Cancer Pipeline 2025: Therapies Under Investigation, Clinical Trials Milestones, and ...

GetNews 04 Apr 2025
EGFR Non Small Cell Lung Cancer companies working in the treatment market are Bridge Biotherapeutics, Inc., Sichuan Kelun Pharmaceutical, BeBetter Med Inc, Avistone ... Sichuan Kelun Pharmaceutical.
Edit

Parenteral Nutrition Market Revenue to Reach $13.60 Billion by 2029, Unlocking Over $5 Billion Opportunities ...

GetNews 24 Mar 2025
To Know More, Click. ... Key Vendors Baxter B.Braun Fresenius Kabi JW Pharmaceutical Sichuan Kelun Pharmaceutical Grifols Aculife Healthcare Albert David Amanta Healthcare American Regent Axa Parenterals Ltd BML Parenteral Drugs Caritas Healthcare Pvt.
  • 1
×